Intrahepatic CD69+Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression
Background More than 50% of all patients with colorectal cancer (CRC) develop liver metastases (CLM), a clinical condition characterized by poor prognosis and lack of reliable prognostic markers. Vδ1 cells are a subset of tissue-resident gamma delta (γδ) T lymphocytes endowed with a broad array of a...
Sparad:
| Huvudupphov: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMJ Publishing Group
2022-07-01
|
| Serie: | Journal for ImmunoTherapy of Cancer |
| Länkar: | https://jitc.bmj.com/content/10/7/e004579.full |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
